Shvarts GY. Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis. Ukr Neurosurg J [Internet]. 2005Jun.16 [cited 2024Nov.29];(2):85-91. Available from: https://theunj.org/article/view/132316